XANAX Drug Patent Profile

✉ Email this page to a colleague

When do Xanax patents expire, and what generic alternatives are available?

Xanax is a drug marketed by Upjohn and is included in two NDAs.

The generic ingredient in XANAX is alprazolam. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the alprazolam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Xanax

A generic version of XANAX was approved as alprazolam by NOVITIUM PHARMA on October 19^th, 1993.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for XANAX?
What are the global sales for XANAX?
What is Average Wholesale Price for XANAX?

Summary for XANAX

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	53
Patent Applications:	6,657
Drug Prices:	Drug price information for XANAX
Drug Sales Revenues:	Drug sales revenues for XANAX
What excipients (inactive ingredients) are in XANAX?	XANAX excipients list
DailyMed Link:	XANAX at DailyMed

Drug patent expirations by year for XANAX

Pharmacology for XANAX

Drug Class	Benzodiazepine

US Patents and Regulatory Information for XANAX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Upjohn	XANAX XR	alprazolam	TABLET, EXTENDED RELEASE;ORAL	021434-003	Jan 17, 2003	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-004	Nov 27, 1985	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Upjohn	XANAX XR	alprazolam	TABLET, EXTENDED RELEASE;ORAL	021434-004	Jan 17, 2003	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for XANAX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-004	Nov 27, 1985	⤷ Sign Up	⤷ Sign Up
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-004	Nov 27, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for XANAX

See the table below for patents covering XANAX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
United Kingdom	1291631		⤷ Sign Up
Philippines	10798	METHOD OF TREATMENT USING 8-CHLORO-1-METHYL-6-PHENYL-4H-S-TRIAZOLO-(4,3,A)(1,4)-BENZODIAZEPINE COMPOSITIONS	⤷ Sign Up
South Africa	7201488		⤷ Sign Up
Belgium	747493		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for XANAX

Pharmacology for XANAX

Make Better Decisions: Try a trial or see plans & pricing